PL362365A1 - Nowy sposób syntezy przemysłowej ranelatu strontui jego hydratów oraz sposób syntezy przemysłowej diestrów kwasu 5-amino-4-cyjano-3-karboksymetylo-2-tiofenokarboksylowego - Google Patents

Nowy sposób syntezy przemysłowej ranelatu strontui jego hydratów oraz sposób syntezy przemysłowej diestrów kwasu 5-amino-4-cyjano-3-karboksymetylo-2-tiofenokarboksylowego

Info

Publication number
PL362365A1
PL362365A1 PL03362365A PL36236503A PL362365A1 PL 362365 A1 PL362365 A1 PL 362365A1 PL 03362365 A PL03362365 A PL 03362365A PL 36236503 A PL36236503 A PL 36236503A PL 362365 A1 PL362365 A1 PL 362365A1
Authority
PL
Poland
Prior art keywords
industrial synthesis
thiophenokarboxylic
karboxyl
diesters
hydrates
Prior art date
Application number
PL03362365A
Other languages
English (en)
Other versions
PL214400B1 (pl
Inventor
Lucile Vaysse-Ludot
Jean-Pierre Lecouve
Pascal Langlois
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of PL362365A1 publication Critical patent/PL362365A1/pl
Publication of PL214400B1 publication Critical patent/PL214400B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Inorganic Insulating Materials (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL362365A 2002-09-24 2003-09-23 Sposób syntezy przemyslowej ranelinianu strontu oraz sposób syntezy przemyslowej diestrów kwasu 5-amino-4-cyjano-3-karboksymetylo-2-tiofenokarboksylowego PL214400B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0211763A FR2844795B1 (fr) 2002-09-24 2002-09-24 Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates

Publications (2)

Publication Number Publication Date
PL362365A1 true PL362365A1 (pl) 2004-04-05
PL214400B1 PL214400B1 (pl) 2013-07-31

Family

ID=29415189

Family Applications (1)

Application Number Title Priority Date Filing Date
PL362365A PL214400B1 (pl) 2002-09-24 2003-09-23 Sposób syntezy przemyslowej ranelinianu strontu oraz sposób syntezy przemyslowej diestrów kwasu 5-amino-4-cyjano-3-karboksymetylo-2-tiofenokarboksylowego

Country Status (37)

Country Link
US (1) US7214805B2 (pl)
EP (1) EP1403266B1 (pl)
JP (1) JP4136867B2 (pl)
KR (1) KR100551501B1 (pl)
CN (1) CN1212321C (pl)
AP (1) AP1910A (pl)
AR (1) AR041355A1 (pl)
AU (2) AU2003248281B2 (pl)
BR (1) BR0304213A (pl)
CA (1) CA2442878C (pl)
CR (1) CR7764A (pl)
CY (1) CY1115162T1 (pl)
DK (1) DK1403266T3 (pl)
EA (1) EA007489B1 (pl)
EC (1) ECSP055741A (pl)
ES (1) ES2478620T3 (pl)
FR (1) FR2844795B1 (pl)
GE (1) GEP20074215B (pl)
HR (1) HRP20050359B1 (pl)
IL (1) IL167316A (pl)
IS (1) IS7807A (pl)
MA (1) MA26102A1 (pl)
ME (1) ME00455B (pl)
MX (1) MXPA03008643A (pl)
MY (1) MY134921A (pl)
NO (1) NO328638B1 (pl)
NZ (1) NZ528402A (pl)
OA (1) OA12934A (pl)
PL (1) PL214400B1 (pl)
PT (1) PT1403266E (pl)
RS (2) RS20050240A (pl)
SG (1) SG110071A1 (pl)
SI (1) SI1403266T1 (pl)
TN (1) TNSN05087A1 (pl)
UA (1) UA79156C2 (pl)
WO (1) WO2004029036A1 (pl)
ZA (1) ZA200307409B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2275218T3 (es) * 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
EP1622630B1 (en) * 2003-05-07 2012-08-29 Osteologix A/S Strontium combinations for the prophylaxis/treatment of cartilage and/or bone conditions
US20080167513A1 (en) * 2004-02-26 2008-07-10 Osteologlx A/S Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions
US7589235B2 (en) * 2004-05-06 2009-09-15 Osteologix, A/S High yield and rapid synthesis methods for producing metallo-organic salts
CA2571449C (en) 2004-06-25 2015-12-08 John Nikolaj Hvarre Christensen Compositions comprising strontium and vitamin d and uses thereof
FR2875807B1 (fr) * 2004-09-30 2006-11-17 Servier Lab Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN100538672C (zh) * 2005-04-18 2009-09-09 索尼株式会社 控制设备和方法
CN100391955C (zh) * 2005-04-30 2008-06-04 河北医科大学 一种雷尼酸锶中间体的合成方法
AU2006281157B2 (en) * 2005-08-19 2013-03-28 Glenmark Pharmaceuticals Limited Process for the preparation of strontium ranelate
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
FR2921367B1 (fr) * 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates
US20120123131A1 (en) * 2008-08-22 2012-05-17 Koilpillai Joseph Prabahar Process for the preparation of strontium ranelate
HU228820B1 (en) 2010-01-14 2013-05-28 Richter Gedeon Nyrt Process for the preparation of distrontium ranelate
WO2011110597A1 (de) 2010-03-11 2011-09-15 Azad Pharmaceutical Ingredients Ag Verfahren zur herstellung von strontiumranelat
WO2011124992A1 (en) * 2010-03-24 2011-10-13 Actavis Group Ptc Ehf Substantially pure strontium ranelate
WO2013013003A1 (en) 2011-07-21 2013-01-24 Emory University Methods for treating inflamatory conditions and states, and cancers by antagonizing nf-kb activation
CN102321068B (zh) * 2011-08-01 2013-01-23 山东铂源药业有限公司 一种雷奈酸锶的制备方法
WO2013175270A1 (en) * 2012-05-25 2013-11-28 Fleming Laboratories Limited Improved process for the preparation of strontium ranelate hydrates and new polymorphic form of monohydrate
EP2756841B1 (en) 2013-01-21 2015-05-13 Galenicum Health S.L. Pharmaceutical compositions comprising an acid salt
CN103319454B (zh) * 2013-06-14 2014-06-18 广东众生药业股份有限公司 一种高纯度雷尼酸四乙酯及其中间体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
FR2844797B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844796A1 (fr) * 2002-09-24 2004-03-26 Servier Lab Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates

Also Published As

Publication number Publication date
US7214805B2 (en) 2007-05-08
EP1403266B1 (fr) 2014-04-09
EA200300925A1 (ru) 2004-04-29
OA12934A (en) 2006-10-13
FR2844795B1 (fr) 2004-10-22
HK1065791A1 (en) 2005-03-04
AP2005003256A0 (en) 2005-03-31
AU2003248281B2 (en) 2009-08-06
SG110071A1 (en) 2005-04-28
ECSP055741A (es) 2005-07-06
KR20040026625A (ko) 2004-03-31
AU2003282179A1 (en) 2004-04-19
RS53509B1 (sr) 2015-02-27
UA79156C2 (en) 2007-05-25
CY1115162T1 (el) 2016-12-14
NZ528402A (en) 2004-07-30
MY134921A (en) 2008-01-31
MXPA03008643A (es) 2005-04-19
TNSN05087A1 (fr) 2007-05-14
ZA200307409B (en) 2004-07-07
IS7807A (is) 2005-04-19
CA2442878A1 (fr) 2004-03-24
HRP20050359B1 (hr) 2014-09-26
CN1496986A (zh) 2004-05-19
NO20034235D0 (no) 2003-09-23
CR7764A (es) 2005-10-06
AP1910A (en) 2008-10-30
PL214400B1 (pl) 2013-07-31
PT1403266E (pt) 2014-05-06
GEP20074215B (en) 2007-10-10
JP2004149516A (ja) 2004-05-27
ES2478620T3 (es) 2014-07-22
IL167316A (en) 2008-08-07
MA26102A1 (fr) 2004-04-01
EA007489B1 (ru) 2006-10-27
JP4136867B2 (ja) 2008-08-20
NO328638B1 (no) 2010-04-12
AR041355A1 (es) 2005-05-11
WO2004029036A1 (fr) 2004-04-08
KR100551501B1 (ko) 2006-02-13
EP1403266A1 (fr) 2004-03-31
HRP20050359A2 (en) 2005-06-30
RS20050240A (sr) 2007-06-04
NO20034235L (no) 2004-03-25
AU2003248281A1 (en) 2004-04-08
BR0304213A (pt) 2004-08-31
DK1403266T3 (da) 2014-07-07
ME00455B (me) 2011-10-10
FR2844795A1 (fr) 2004-03-26
SI1403266T1 (sl) 2014-06-30
US20040063972A1 (en) 2004-04-01
CA2442878C (fr) 2009-03-03
CN1212321C (zh) 2005-07-27

Similar Documents

Publication Publication Date Title
PL362365A1 (pl) Nowy sposób syntezy przemysłowej ranelatu strontui jego hydratów oraz sposób syntezy przemysłowej diestrów kwasu 5-amino-4-cyjano-3-karboksymetylo-2-tiofenokarboksylowego
IL164002A0 (en) Sulfonyl-derivatives as novel inhibitors of histone deacetylase
IL164003A0 (en) Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
EP1507756A4 (en) CCR9 INHIBITORS AND USE THEREOF
EP1549316A4 (en) HAMMER OF TFGbeta
AU2003217870A8 (en) Pini-modulating compounds and methods of use thereof
AU2003303128A8 (en) Inhibitors and methods of use thereof
AU2003213673A8 (en) Pin1-modulating compounds and methods of use thereof
EP1539193A4 (en) HYALURONIC ACID COMPOSITIONS AND METHODS OF USE
AU2003288902A8 (en) Microcapsules and methods of use
EP1534680A4 (en) PRENYLATION INHIBITORS AND METHODS FOR THEIR SYNTHESIS AND APPLICATION
IL164295A0 (en) Tri-substituted heteroaryls and methods of making and using the same
AU2003236991A8 (en) Representations of processes
AU2003243714A8 (en) Etoposide analogs and methods of use thereof
AU2003295410A8 (en) Piston and method of manufacture
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
EP1487776A4 (en) ACID COMPOUNDS AND ESTERS AND METHODS OF USE THEREOF
PL371217A1 (pl) Inhibitory integryny alfaVbeta6
EP1492868A4 (en) METHOD FOR INFLAMMATORY RESPONSE MODULATION
AU2003275056A8 (en) Novel lapacho compounds and methods of use thereof
IL153232A0 (en) PREPARATION OF CaBr2 HYDRATES AND USES THEREOF
PL373163A1 (pl) Sól (S)-pantoprazolu i jej hydraty
AU2003265394A8 (en) Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
AU2003282593A8 (en) Polyphenolamine composition and method of use
AU2003267944A8 (en) Novel trifluoromethylepinephrine compounds and methods of making and using thereof